Next Article in Journal
Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
Next Article in Special Issue
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
Previous Article in Journal
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment
Previous Article in Special Issue
Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer
 
 
Review

Article Versions Notes

Cancers 2021, 13(10), 2413; https://doi.org/10.3390/cancers13102413
Action Date Notes Link
article pdf uploaded. 17 May 2021 11:24 CEST Version of Record https://www.mdpi.com/2072-6694/13/10/2413/pdf-vor
article xml file uploaded 20 May 2021 07:34 CEST Original file -
article xml uploaded. 20 May 2021 07:34 CEST Update https://www.mdpi.com/2072-6694/13/10/2413/xml
article pdf uploaded. 20 May 2021 07:34 CEST Updated version of record https://www.mdpi.com/2072-6694/13/10/2413/pdf
article html file updated 20 May 2021 07:36 CEST Original file -
article html file updated 26 July 2022 19:52 CEST Update https://www.mdpi.com/2072-6694/13/10/2413/html
Back to TopTop